
Epic Showdown: Ozempic Debate Explodes
Keeping It Real: Conversations with Jillian Michaels
00:00
Examining Thyroid Risks of GLP-1 Agonists
This chapter critically explores the potential thyroid cancer risks linked to GLP-1 receptor agonists, highlighting key studies and historical data. The discussion addresses the rarity of thyroid cancer incidents in humans compared to animals, the implications of detection bias, and the necessity of randomized control trials to clarify the actual risks.
Play episode from 58:46
Transcript


